Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic ...
In this article, we are going to take a look at where Zoetis Inc. (NYSE:ZTS) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year ...
The Wall Street Journal released an article claiming that Zoetis' OA pain drug (Librela) is not safe. I go over these claims and explain why I believe they are unfounded. Librela might face a ...
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic ...
Shares of Zoetis (NYSE:ZTS) traded lower on Tuesday after the U.S. FDA notified veterinarians about adverse events linked to the company’s pain therapy, Librela (bedinvetmab injection ...
Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb. Wall Street Rallies On Election Day, Palantir Skyrockets, Bitcoin Tops $70,000: What's Driving Markets Tuesday? Wall Street rallied ...
Analyst Michael Ryskin of Bank of America Securities maintained a Buy rating on Zoetis (ZTS – Research Report), retaining the price target of $210.00. Discover top-rated stocks from highly ...
Update 1:25 PM EST: Adds latest stock move and comments from Bank of America Zoetis (NYSE:ZTS) shares reached a new 52-week low on Friday after The Wall Street Journal reported widespread adverse ...
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of Zoetis Inc (Symbol: ZTS) entered into oversold territory, hitting an RSI reading of 29.6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results